
DMT
{The Spirit Molecule, Jungle Spice, Dimitri, the Businessman’s trip, Fantasia}
Put your brand in front of thousands monthly and support the growth of harm reduction.
The Law
Europe
United Kingdom
DMT is a class A/schedule 1 drug, making it illegal to possess purchase or sell.
Germany
DMT is listed in Anlage 1 of the BtMG, making it illegal to possess, purchase or sell.
France
DMT, along with most of its plant sources, is classified as a stupéfiant (narcotic).
Netherlands
DMT is banned and is on list 1 of the Opium Act. Producing, trading or possession of DMT is prohibited.
Portugal
Decriminalized drug possession in quantities for personal use
Russia
DMT is listed as schedule 1, making it illegal to possess purchase or sell.
Americas
USA
DMT is classified as a Schedule I drug under the Controlled Substances Act of 1970.
Canada
DMT is listed as a schedule 3 drug.
Peru
Legal in ayahuasca and declared as a national cultural heritage.
Brazil
Legal in ayahuasca and declared as a national cultural heritage since 1992.
Ecuador
Decriminalized in ayahuasca.
Asia and Australasia
Australia
Illegal
New Zealand
Illegal. Class A drug
Singapore
Illegal
Hong Kong
Illegal
Israel
Illegal
References
Websites
https://psychonautwiki.org/wiki/DMT
https://www.medicalnewstoday.com/articles/306889.php
https://erowid.org/chemicals/dmt/dmt.shtml
https://erowid.org/library/books\_online/tihkal/tihkal06.shtml
https://erowid.org/chemicals/dmt/dmt\_culture1.shtml
https://www.legislation.gov.uk/ukpga/1971/38/contents
Papers
Barker, S. (2018). N, N-Dimethyltryptamine (DMT), an Endogenous Hallucinogen: Past, Present, and Future Research to Determine Its Role and Function. Frontiers in Neuroscience, 12.
Nichols, D. (2016). Psychedelics. Pharmacological Reviews, 68(2), pp.264-355.
dos Santos, R., Bouso, J. and Hallak, J. (2017). Ayahuasca, dimethyltryptamine, and psychosis: a systematic review of human studies. Therapeutic Advances in Psychopharmacology, 7(4), pp.141-157.
Strassman, R. J. (1984). Adverse reactions to psychedelic drugs. A review of the literature. The Journal of Nervous and Mental Disease, 172(10), 577-595.
Szabo, A. and Frecska, E. (2016). Dimethyltryptamine (DMT): a biochemical Swiss Army knife in neuroinflammation and neuroprotection?. Neural Regeneration Research, 11(3), p.396.
Put your brand in front of thousands monthly and support the growth of harm reduction.